Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-01-06 @ 1:17 PM
Study NCT ID:
NCT01183169
Status:
COMPLETED
Last Update Posted:
2016-08-25
First Post:
2010-08-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
Sponsor:
Debiopharm International SA
Organization: